Madhya Bharat Agro Products Ltd

Q2 FY25Fertilizers & Agrochemicals

Madhya Bharat Agro Products Ltd Q2 FY25 Results & Presentation Highlights: Revenue, Margins & Order Book

Q2 FY25 investor presentation: what the company reported on revenue, margins and projects.

Price₹164

Market cap₹7.0K Cr

P/E45.2

Updated25 Sept 2026

Read4 min read

Based on Madhya Bharat Agro Products Ltd's Q2 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q2 FY25 Revenue from operations: Rs. Q2 FY25 Financials: - EBITDA: Rs.

From Madhya Bharat Agro Products Ltd's Q2 FY25 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

Q2 FY25 Revenue from operations: Rs. 278.3 crore, virtually flat YoY (-0.1%) compared to Q2 FY24 (Rs. 278.5 crore).
QoQ Revenue growth: 38.9% increase from Q1 FY25 (Rs. 200.4 crore).
Sales volume for Q2 FY25:
SSP: 60.4 thousand tons (up 7.1% YoY, 38.9% QoQ)
NPK: 42.2 thousand tons (up 27.9% YoY, 34.4% QoQ)
EBITDA: Rs. 38 crore, down 7.7% YoY, up 7.9% QoQ.
PAT: Rs. 13.8 crore, down 7.3% YoY, up 20.5% QoQ.

2 more points management made on revenue & sales performance

Profitability & Margins

Q2 FY25 Financials:
EBITDA: Rs. 38.0 crore, down 7.7% YoY (from Rs. 41.2 crore in Q2 FY24)
EBITDA Margin: 13.6%, down 118 bps YoY (from 14.8% in Q2 FY24)
Profit After Tax (PAT): Rs. 13.8 crore, down 7.3% YoY (from Rs. 14.9 crore in Q2 FY24)
PAT Margin: 5.0%, down 39 bps YoY (from 5.4% in Q2 FY24)
Year-on-Year Changes:
EBITDA decreased by 7.7%
PAT decreased by 7.3%
Margins (EBITDA and PAT) reduced by 118 bps and 39 bps respectively

2 more points management made on profitability & margins

See what Madhya Bharat Agro Products Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Planned Capacity Addition at Nardana (Maharashtra):
DAP/NPK: 330,000 MTPA (fungible granulation plant)
Phosphoric Acid: 99,000 MTPA
Sulphuric Acid: 198,000 MTPA
Expected commissioning: October 2026 (Page 14)
Brownfield Expansion at Sagar (Madhya Pradesh):
Phosphoric Acid capacity increase by 33,000 MT
Plant being relocated from Dahej to Nardana
Site development in progress (Pages 13-14)
Total Expansion Capex: Rs. 600 crore
Maharashtra: Rs. 535 crore
Madhya Pradesh: Rs. 70 crore (Page 14)
Recent Capacity Enhancements:
Sulphuric Acid capacity increased from 99,000 MTPA to 165,000 MTPA in 4QFY24 (Pages 9, 23)
Future Commissioning Timelines:

2 more points management made on capital expenditure plans

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential

1Anya Polytech & Fertilizers Ltd₹180 Cr

Rev 2Mar 1

2Dharmaj Crop₹934 Cr

Rev 2Mar 2

3₹5.6K Cr

Rev 2Mar 3

4₹114 Cr

Rev 2Mar 3

5₹1.3K Cr

Rev 3Mar 1

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The presentation does not explicitly mention any new fundraising through debt or equity.
Cash Flow Summary (Page 28) shows net cash used in financing activities of Rs. 61.36 crore in FY2024, indicating some repayment or outflow from financing but no mention of raising new funds.
Total Debt increased from Rs. 37.04 crore in FY2020 to Rs. 289.62 crore in FY2024 (Page 29), showing an overall increase in borrowings over years, but no specific fundraising event detailed.
Debt-Equity Ratio rose to 0.83 in FY2024 from 0.28 in FY2020, implying higher leverage.

2 more points management made on fundraising & capital structure

See what Madhya Bharat Agro Products Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation for Madhya Bharat Agro Products Ltd. does not specifically mention or report any details regarding order book, order inflow, or pending orders. The presentation covers the following areas without reference to order status: - Financial performance, including revenue, EBITDA, PAT, margins, and key ratios. - Operational and manufacturing capacity. - Product portfolio and market share. - Strategic advantages such as backward integration and geographic location.

2 more points management made on order book & pipeline

Madhya Bharat Agro Products Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹395 Cr, net profit ₹60 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What M B Agro Prod.'s management said in earlier quarters

Compare:vs Coromandel Inter vs F A C T vs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Madhya Bharat Agro Products Ltd Q2 FY25 results?

Q2 FY25 Revenue from operations: Rs. Q2 FY25 Financials: - EBITDA: Rs.

What is Madhya Bharat Agro Products Ltd share price analysis?

Madhya Bharat Agro Products Ltd currently shows a neutral. The stock trades at a P/E of 45.2 with a market cap of ₹7,002 Cr. Investors should review the full earnings analysis for detailed insights.

Is Madhya Bharat Agro Products Ltd planning capital expenditure?

Planned Capacity Addition at Nardana (Maharashtra): - DAP/NPK: 330,000 MTPA (fungible granulation plant) - Phosphoric Acid: 99,000 MTPA - Sulphuric Acid: 198,000 MTPA - Expected commissioning: October 2026 (Page 14) - Brownfield Expansion at Sagar (Madhya Pradesh): - Phosphoric Acid capacity increase by 33,000 MT - Plant being relocated from Dahej to Nardana - Site development in progress (Pages 13-14) - Total Expansion Capex: Rs.

Keep Madhya Bharat Agro Products Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.